rochester medical corp (ROCM:NASDAQ GM)
rochester medical corp (ROCM) Snapshot
|
Open
$14.56
|
Previous Close
$14.66
|
|
|
Day High
$14.70
|
Day Low
$14.51
|
|
|
52 Week High
04/11/13 - $15.34
|
52 Week Low
11/13/12 - $9.11
|
|
|
Market Cap
180.9M
|
Average Volume 10 Days
28.0K
|
|
|
EPS TTM
$0.31
|
Shares Outstanding
12.3M
|
|
|
EX-Date
--
|
P/E TM
47.3x
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
rochester medical corp (ROCM) Related Businessweek News
No Related Businessweek News Foundrochester medical corp (ROCM) Details
Rochester Medical Corporation engages in the development, manufacture, and marketing of PVC-free and latex-free urinary continence and urine drainage care products for the home and acute care markets. Its home care products include silicone male external catheters (MECs) under the UltraFlex, Pop-On, Wide Band, Natural, Clear Advantage, Transfix, and Spirit names for managing male urinary incontinence; latex MECs under the Freedom and Freedom Plus names for managing male urinary incontinence; intermittent catheters, such as standard, antibacterial, hydrophilic, and antibacterial personal catheters in various diameters for male, female, and pediatric use; and the FemSoft Insert, a liquid-filled urethral insert for managing stress urinary incontinence in adult females. The company’s acute care products comprise standard and StrataSI silicone Foley catheters, as well as StrataNF catheter, an antibacterial Foley catheter that reduces the incidence of hospital acquired urinary tract infection. It also distributes ostomy, and wound and scar care products and accessories; anti-decubitis mattresses; and other branded urological products. Rochester Medical Corporation offers its products to distributors, individual hospitals, healthcare institutions, and extended care facilities. The company markets its products primarily under the Rochester Medical brand name through a direct sales force in the United States, the United Kingdom, and the Netherlands; and supplies to various medical product companies and group purchasing organizations, as well as markets through independent distributors in other international markets. Rochester Medical Corporation was founded in 1988 and is headquartered in Stewartville, Minnesota.
rochester medical corp (ROCM) Top Compensated Officers
rochester medical corp (ROCM) Key Developments
Rochester Medical Corporation announced unaudited consolidated earnings results for the second quarter and six months ended March 31, 2013. For the quarter, the company reported sales of $16,635,070 against $15,427,275 a year ago. Income from operations was $1,773,223 against $834,331 a year ago. Net income before income taxes was $1,723,142 against $884,113 a year ago. Net income was $1,199,250 or $0.10 per diluted share against $602,514 or $0.05 per diluted share a year ago. Non-GAAP net income was $1,488,250 or $0.12 per diluted share against $920,000 or $0.08 per diluted share a year ago. The 113% increase in GAAP operating income drove an incremental operating margin of 79% in the second quarter. For the six months period, the company reported sales of $33,887,078 against $29,399,882 a year ago. Income from operations was $3,150,727 against $813,602 a year ago. Net income before income taxes was $3,110,909 against $772,314 a year ago. Net income was $2,211,395 or $0.18 per diluted share against $527,167 or $0.04 per diluted share a year ago. Non-GAAP net income was $2,914,395 or $0.23 per diluted share against $1,204,000,000 or $0.10 per diluted share a year ago. The company reaffirms guidance for fiscal 2013, sales of approximately $67 million. This represents growth of approximately 17% year-over-year, excluding Foley sales in both periods. The company also reaffirms after-tax profit guidance of approximately $7 million.
Rochester Medical Corporation, Q2 2013 Earnings Call, Apr 25, 2013
Rochester Medical Corporation announced that they will report Q2, 2013 results at 5:00 PM, Eastern Standard Time on Apr 25, 2013
| Recently Viewed | |||
| ROCM:US | $14.66 USD | 0.00 | |
| Company | Last | Change |
| Coloplast A/S | kr326.50 DKK | -0.50 |
| Covidien PLC | $65.17 USD | -0.04 |
| CR Bard Inc | $105.14 USD | -0.01 |
| Kimberly-Clark Corp | $103.51 USD | +0.97 |
| Teleflex Inc | $78.71 USD | +0.41 |
| View Industry Companies | ||
Industry Analysis
ROCM
Industry Average
| Valuation | ROCM | Industry Range |
| Price/Earnings | 48.9x |
|
| Price/Sales | 2.7x |
|
| Price/Book | 2.6x |
|
| Price/Cash Flow | 48.4x |
|
| TEV/Sales | 2.4x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact ROCHESTER MEDICAL CORP, please visit www.rocm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








